Literature DB >> 7623762

Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7623762

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  278 in total

1.  Effects of OspA vaccination on Lyme disease serologic testing.

Authors:  M E Aguero-Rosenfeld; J Roberge; C A Carbonaro; J Nowakowski; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens.

Authors:  S Bas; P Muzzin; B Ninet; J E Bornand; C Scieux; T L Vischer
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Epstein-Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis.

Authors:  H A Goossens; M K Nohlmans; A E van den Bogaard
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

Review 5.  Laboratory testing for Lyme disease: possibilities and practicalities.

Authors:  Kurt D Reed
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Role of adrenomedullin in Lyme disease.

Authors:  Meghan L Marre; Courtney T Darcy; Janeth Yinh; Shizuo Akira; Satoshi Uematsu; Allen C Steere; Linden T Hu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

7.  A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis.

Authors:  J Robertson; E Guy; N Andrews; B Wilske; P Anda; M Granström; U Hauser; Y Moosmann; V Sambri; J Schellekens; G Stanek; J Gray
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

8.  Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.

Authors:  Adriana R Marques; Dale S Martin; Mario T Philipp
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.

Authors:  Joseph L Gugliotta; Heidi K Goethert; Victor P Berardi; Sam R Telford
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

10.  Cytokine profile in serum and synovial fluid of arthritis patients with Chlamydia trachomatis infection.

Authors:  Michael C Jendro; Elke Raum; Sebastian Schnarr; Lars Köhler; Henning Zeidler; Jens G Kuipers; Michael Martin
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.